Fig. 6: Patient-reported outcomes. | Nature Communications

Fig. 6: Patient-reported outcomes.

From: Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial

Fig. 6: Patient-reported outcomes.The alt text for this image may have been generated using AI.

A Evolution of EQ-5D-5L score over time. B Physical fatigue (per FA-12) over time. C QLQ-C30 GHS/HRQoL over time. D Time to first 10-point deterioration in GHS/HRQoL. CI confidence interval, GHS global health status, HRQoL health-related quality of life.

Back to article page